An Open-Label Trial of Pregabalin in Patients With Fibromyalgia
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
The main purpose of this protocol is to evaluate the long-term safety of pregabalin in
patients who participated in the previous fibromyalgia Study A0081056 and who wish to receive
open-label pregabalin therapy.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.